Beaudet, M-J., M. Desrochers, A. Lachaud & A. Anderson (2005). "The CYP2B2 phenobarbital response unit contains binding sites for hepatocyte nuclear factor 4, PBX-Prep1, the thyroid hormone receptor ß, and the liver X receptor", Biochem. J. 388(Pt 2): 407-18,
Roberge, C., M-J. Beaudet and A. Anderson (2004). "GABAA/central benzodiazepine receptor and peripheral benzodiazepine receptor ligands as inducers of phenobarbital-inducible CYP2B and CYP3A", Biochem. Pharamcol. 68, 1383-1389,
Paquet,Y. E. Trottier, M-J. Beaudet & A. Anderson (2000). "Mutational analysis of the CYP2B2 phenobarbital response unit and inhibitory effect of the constitutive androstane receptor on phenobarbital responsiveness", J. Biol. Chem. 275, 38427-38436,
Courtemanche,C. & A. Anderson (1999). "Multiple mutations in a shuttle vector modified by ultraviolet irradiation, (±)7,8-dihydroxy-9,10- epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene, and aflatoxin B1 have different properties than single mutations and may be generated during translesion synthesis", Mutat. Res. 430, 23-36,
Courtemanche, C. & A. Anderson (1999). "The p53 tumor suppressor protein reduces point mutation frequency of a shuttle vector modified by the chemical mutagens (±)7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo [a]pyrene, aflatoxin B1 and meta-chloroperoxybenzoic acid", Oncogene, 18, 4672-4680,
Département de biologie, Pavillon Alexandre-Vachon, 1045, av. de la Médecine, Local 3058
Québec (Québec) G1V 0A6 Canada
Téléphone : 418 656-3180 Courriel :info@bio.ulaval.ca
